Tanja Obradovic, PhD

Media Releases

Get to know VP of Oncology Scientific Affairs Dr. Tanja Obradovic, a Clinical Pharmacologist who resides in Philadelphia, Pennsylvania. 

Dr. Obradovic is an accomplished executive drug development strategy leader with a distinguished career spanning over two decades, marked by a rich blend of academic and industry experiences in the field of clinical Oncology drug development and medical affairs. Her commitment to innovation, teamwork, personal accountability, and excellence has shaped her into a respected figure in the pharmaceutical industry.

Before embarking on her professional journey, the doctor began her academic journey at the University of Belgrade, where she earned her Bachelor of Science in Molecular Biology and Physiology. Building upon this foundation, she pursued advanced studies at Washington State University, obtaining a Doctor of Philosophy (Ph.D.) in Pharmacology and Toxicology.

Notably, Dr. Obradovic has played a significant role in the clinical development, filing and approval processes of the major PD1 inhibitor in over 50 countries worldwide, spanning regions such as the United States, Europe, Asia, and Latin America. Her leadership in medical strategy focused on Oncology immunotherapy, where she has shaped new treatment options, value and reimbursement policies. This involves the creation of a comprehensive drug development strategy across early to late-stage clinical steps, and access packages tailored for major regulatory and treatment guidance bodies as well as private and public insurers in the US and globally.

Clinical pharmacology is the science of drugs in humans and their optimal clinical use in patients. It is underpinned by the basic science of pharmacology, with an added focus on the application of pharmacological principles and quantitative methods in the real human patient population. Clinical pharmacologists are doctors with training in clinical pharmacology and therapeutics (CPT), which is the science of medicines and their clinical use. Their main role is to improve patient care through the safe, economic and effective use of medicines.

Recommended Articles

• The Latest Advancements in Treatment and Research for Rheumatoid Arthritis

  Patients and providers alike are often faced with unique challenges when it comes to treatment for Rheumatoid Arthritis (RA). The disease is not well understood, there is no cure, and treatments often require a trial and error process.Luckily, technology and research are constantly advancing...

• What Is the Treatment of Choice for Pneumonia?

  Pneumonia is a lung infection that affects the air sacs. The sacs are either filled with fluid or pus causing a cough with phlegm. The symptoms of pneumonia range from mild to severe, which could be life-threatening. People from all age groups, from infants to old age, people with other health...

• Musician Joseph Shabason Reflects On His Family's Parkinson's in Album

  "It's a weird thing to talk about, because I think so much of the time when people around you are sick, the overwhelming emotion is, like, you feel bad for them and you want to be there for them and love them, but when someone around you is sick, it often puts a tremendous burden on the people in...

• What is Post Partum Depression?

  Mood swings are normal after giving birth. Your emotions could be so high then down the next minute. These changes in emotion is called post partum baby blues, which begins two to three days after giving birth and usually lasts for two weeks.On the other hand, some moms or new moms experience severe...

• What Is Renal Ultrasound Used For?

  A renal ultrasound is actually a diagnostic procedure, wherein high-frequency sound waves are transmitted through the body tissues that are inaudible to the human ear. The echoes recorded into videos or images of the internal structures of the body.A wide range of diseases and conditions can be...

• Penicillin and Other Drugs in the Same Class

  About PenicillinPenicillin is an antibiotic derived from the Penicillium notatum mold. In 1928, a Scottish bacteriologist named Alexander Fleming discovered penicillin. Since Fleming's discovery, several penicillins have been derived through modifying the mold's original structure to produce...